Join the club for FREE to access the whole archive and other member benefits.

Can we treat the ageing process or not? That's the question

John Newman, UCSF asst prof & Buck Institute researcher, explains upcoming ageing interventions

02-Jan-2020

Key points from article :

By 2050 the global population age 65 and older is projected to nearly triple, to 1.5 billion.

Geroscience seeks to understand the relationship between aging, disease, and quality of life.

Clinical trials are looking at whether metformin will slow the rate of chronic diseases in older people.

Treating older adults with TOR inhibitors can reduce the rate of age-related respiratory infections.

In 2050 it might be possible to treat your senescent cells or your autophagy by visiting primary care doctor.

Mentioned in this article:

Click on resource name for more details.

Buck Institute

Independent biomedical research institute focused on aging

John Newman

Geriatrician, basic science researcher, and educator at the Buck Institute and the UCSF

Topics mentioned on this page:
Ageing Research, Metformin